Salon, Margarita .
HRN: 11-58-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/15/2022
10/21/2022
IV
500mg
Q8
Decubitus Ulcer Sacral Grade 2
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes